Gene Symbol | Pearson Correlation Coefficient |
---|---|
OR56A4 | 0.918 |
PRDM14 | 0.911 |
PRAMEF17 | 0.909 |
OR10K1 | 0.903 |
TAS2R41 | 0.899 |
TAS2R30 | 0.896 |
POU5F2 | 0.893 |
TMEM247 | 0.885 |
OR9Q2 | 0.884 |
OR2A14 | 0.884 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
FBXL22 | -0.308 |
CENPH | -0.306 |
NPM3 | -0.294 |
HDDC3 | -0.292 |
NUDT6 | -0.291 |
C11orf80 | -0.282 |
METTL2A | -0.277 |
PDSS2 | -0.27 |
ACRV1 | -0.268 |
CHEK1 | -0.268 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of IFNK mRNA | 24449571 |
C006780 | bisphenol A | bisphenol A results in decreased expression of IFNK mRNA | 25181051 |
C006780 | bisphenol A | bisphenol A results in increased methylation of IFNK gene | 28505145 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased methylation of IFNK promoter | 22457795 |
D003474 | Curcumin | Curcumin results in decreased expression of IFNK mRNA | 18421014 |
D004041 | Dietary Fats | Dietary Fats results in decreased expression of IFNK mRNA | 25016146 |
C406082 | monomethylarsonous acid | monomethylarsonous acid results in decreased expression of IFNK mRNA | 23876855 |
C017947 | sodium arsenite | sodium arsenite results in decreased expression of IFNK mRNA | 23876855 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of IFNK mRNA | 23152189 |
D014241 | Trichloroethylene | Trichloroethylene results in increased methylation of IFNK gene | 27618143 |
D014635 | Valproic Acid | Valproic Acid results in decreased methylation of IFNK gene | 29154799 |
D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of IFNK gene | 25560391 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005125 | cytokine activity | - | IBA | 21873635 |
GO:0005132 | type I interferon receptor binding | - | IBA | 21873635 |
GO:0005132 | type I interferon receptor binding | - | IDA | 11514542 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0002250 | adaptive immune response | - | IBA | 21873635 |
GO:0002286 | T cell activation involved in immune response | - | IBA | 21873635 |
GO:0002323 | natural killer cell activation involved in immune response | - | IBA | 21873635 |
GO:0006355 | regulation of transcription, DNA-templated | - | IDA | 11514542 |
GO:0006959 | humoral immune response | - | IBA | 21873635 |
GO:0008285 | negative regulation of cell proliferation | - | NAS | 11514542 |
GO:0009615 | response to virus | - | IEP | 11514542 |
GO:0010469 | regulation of signaling receptor activity | - | IEA | - |
GO:0019221 | cytokine-mediated signaling pathway | - | IBA | 21873635 |
GO:0019221 | cytokine-mediated signaling pathway | - | IDA | 11514542 |
GO:0030101 | natural killer cell activation | - | NAS | 11514542 |
GO:0030183 | B cell differentiation | - | IBA | 21873635 |
GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein | - | IBA | 21873635 |
GO:0042100 | B cell proliferation | - | IBA | 21873635 |
GO:0043330 | response to exogenous dsRNA | - | IBA | 21873635 |
GO:0045089 | positive regulation of innate immune response | - | TAS | 11514542 |
GO:0051607 | defense response to virus | - | IEA | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005576 | extracellular region | - | IC | 11514542 |
GO:0005615 | extracellular space | - | IBA | 21873635 |
KEGG ID | KEGG Term |
---|---|
hsa04060 | Cytokine-cytokine receptor interaction |
hsa04622 | RIG-I-like receptor signaling pathway |
hsa04630 | Jak-STAT signaling pathway |
Reactome ID | Reactome Term | Evidence |
---|
PMID | Title (Year) | Author | Journal |
---|---|---|---|
23376709 | A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer. (2013 Jul) | Kerns SL | J Urol |